SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
Jun 07, 2019	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001193125-19-168185.pdf 0001193125-19-168185.rtf 0001193125-19-168185.xls View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035096.pdf 0001209191-19-035096.rtf View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035097.pdf 0001209191-19-035097.rtf View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035100.pdf 0001209191-19-035100.rtf View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035104.pdf 0001209191-19-035104.rtf View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035103.pdf 0001209191-19-035103.rtf View HTML
Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-035102.pdf 0001209191-19-035102.rtf View HTML
May 09, 2019	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-19-017525.pdf 0001564590-19-017525.rtf 0001564590-19-017525.xls View HTML
May 09, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Surface Oncology	0001564590-19-017527.pdf 0001564590-19-017527.rtf 0001564590-19-017527.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 08, 2019	EFFECT	EFFECT	Surface Oncology	9999999995-19-001053.pdf 9999999995-19-001053.rtf View HTML

Copyright Morningstar